On Tuesday, TASER International, Inc. (NASDAQ:TASR)’s shares gained 1.91% to $34.65.
Taser International reached a pivotal moment in its history. The company had developed a hot product, an electrical stun gun, but its future was cloudy.
“At the time, it was overly founder-driven,” said Rick Smith, who co-founded Taser (NASDAQ:TASR) with his brother, Tom, in 1993. “My brother and I were feeling overwhelmed.”
Smith admits that he became “a chronic micromanager” even as the company hit $100 million in sales. He prided himself on solving every problem, but doing so stymied his ability to lead effectively.
Starting in 2009, Taser recruited at Harvard, Stanford and other top schools. The firm, based in Scottsdale, Ariz., rotated the newcomers through five or six business units.
“That way, we could see what they were good at, and they could see what they liked the most,” Smith said. “They became free agents within the company to take on projects that came up.”
Taser has put about 30 people through the program, Smith says. Some of its early participants have emerged as top managers at the 500-employee company.
TASER International, Inc. develops, manufactures, and sells conducted electrical weapons (CEWs) worldwide. It operates through two segments, TASER Weapons and AXON. The company’s CEW products transmit electrical pulses along the wires and into the body affecting the sensory and motor functions of the peripheral nervous system. It offers three hand-held CEW product lines, counting TASER X26P and TASER X2, which integrates with EVIDENCE.com; and TASER X26.
At the end of Tuesday’s trade, Glu Mobile Inc. (NASDAQ:GLUU)‘s shares surged 1.84% to $6.63.
Glu Mobile Inc. (GLUU) declared the availability of Terminator Genisys: Revolution on the App Store and Google Play. In partnership with Skydance Productions, Glu has developed the official mobile game in conjunction with the new Terminator Genisys film planned for U.S. theatrical release from Paramount Pictures on July 1, 2015.
Glu Mobile Inc. develops, publishes, and markets a portfolio of games for the smartphones and tablet devices users. The company offers free-to-play action, casual, racing, and sports genre mobile games. It creates games based on its own brands, counting Blood & Glory, Contract Killer, Deer Hunter, Diner Dash, Eternity Warriors, Frontline Commando, Gun Bros, Heroes of Destiny, Racing Rivals, and Tap Sports: Baseball, in addition to based on third-party licensed brands, such as Kim Kardashian: Hollywood, Robocop: The Official Game, and Hercules: The Official Game. Glu Mobile Inc. markets, sells, and distributes its games primarily through direct-to-consumer digital storefronts worldwide.
Horizon Pharma PLC (NASDAQ:HZNP), ended its Tuesday’s trading session with -0.70% loss, and closed at $34.27.
Horizon Pharma PLC (HZNP) pulled back from all-time highs this week, but traders are buying more time for shares to resume their monster rally.
optionMONSTER’s Heat Seeker system detected the sale off 5,000 June 30 calls for $1.40 and the purchase of 5,000 July 32 calls for the ask price of $1.50. Volume was below previous open interest in the near-term contracts, indicating that a long position was rolled forward.
The trader is closing the June contracts, which expire at the end of next week, and paying a net $0.10 to stay in the trade for another month at a higher strike price. The new long calls, which lock in the purchase price of the stock and can provide noteworthy leverage, are looking for shares to rally by expiration in mid-July.
Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
